Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AT-HOME ASSESSMENT OF USABILITY AND DATA COLLECTION FROM A WEARABLE BIOELECTRONIC MONITORING DEVICE.

Proceedings of the ... Design of Medical Devices Conference. Design of Medical Devices Conference·2026
Same author

A Multidimensional Diagnostic Approach for Chronic Obstructive Pulmonary Disease.

JAMA·2025
Same author

Characteristics Associated with Lung Function Trajectories: An Analysis of the SPIROMICS Cohort.

Annals of the American Thoracic Society·2025
Same author

Phenotypes and Trajectories of Tobacco-exposed Persons with Preserved Spirometry: Insights from Lung Volumes.

Annals of the American Thoracic Society·2024
Same author

Polygenic and transcriptional risk scores identify chronic obstructive pulmonary disease subtypes in the COPDGene and ECLIPSE cohort studies.

EBioMedicine·2024
Same author

Polygenic and transcriptional risk scores identify chronic obstructive pulmonary disease subtypes.

medRxiv : the preprint server for health sciences·2024

Related Experiment Video

Updated: Jul 9, 2026

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians
04:03

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians

Published on: September 27, 2024

Exacerbation-free COPD: a goal too far?

Stephen I Rennard1, Tim Higenbottam

  • 1Department of Internal Medicine, Pulmonary and Critical Care Medicine Section, Nebraska Medical Center, Omaha, USA. srennard@unmc.edu

Proceedings of the American Thoracic Society
|December 13, 2007
PubMed
Summary

Chronic obstructive pulmonary disease (COPD) exacerbations worsen symptoms and quality of life. While treatments can reduce frequency and severity, eliminating them remains a significant challenge for patients and clinicians.

Related Experiment Videos

Last Updated: Jul 9, 2026

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians
04:03

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians

Published on: September 27, 2024

Area of Science:

  • Pulmonology
  • Respiratory Medicine
  • Clinical Trials

Background:

  • Chronic obstructive pulmonary disease (COPD) is a progressive respiratory disease.
  • Exacerbations, characterized by acute symptom worsening, increase in frequency and severity as COPD progresses.
  • These events significantly impair quality of life, necessitate hospitalization, and can be fatal.

Framework:

  • The seventh Lund COPD workshop convened to address the persistent challenge of COPD exacerbations.
  • The symposium, "Exacerbation-free COPD, a goal too far?", critically evaluated current therapeutic strategies.
  • The central question focused on the potential for developing more effective treatments to eliminate COPD exacerbations.

Implementation:

  • Current therapies, including antibiotics and corticosteroids, improve exacerbation outcomes.
  • Preventive measures like long-acting bronchodilators, inhaled corticosteroids, and influenza vaccination offer partial protection.
  • Despite existing treatments, no therapy has been found to completely prevent COPD exacerbations.

Implications:

  • Further research is crucial to develop novel therapies capable of eliminating COPD exacerbations.
  • Achieving an exacerbation-free state in COPD patients remains a critical, yet distant, therapeutic goal.
  • Enhanced treatment strategies are needed to significantly improve long-term outcomes and patient well-being in COPD.